Title of article
Testimony from the Bedside: From Coleyʹs Toxins to Targeted Immunotherapy
Author/Authors
Park، نويسنده , , Jin Mo and Fisher، نويسنده , , David E.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2010
Pages
2
From page
9
To page
10
Abstract
A new clinical study reported in the New England Journal of Medicine unveils the long-awaited outcome of anti-CTLA-4 therapy for melanoma. It provides grounds for continued enthusiasm for cancer immunotherapy, deepens our thoughts on underlying mechanisms, and suggests exciting next steps.
Journal title
Cancer Cell
Serial Year
2010
Journal title
Cancer Cell
Record number
1337180
Link To Document